NCT00094835 2016-03-24Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)AmgenPhase 1/2 Completed51 enrolled 23 charts
NCT00101907 2014-03-20Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced CancerAmgenPhase 1 Terminated41 enrolled 17 charts
NCT00101920 2010-10-15ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)AmgenPhase 2 Completed50 enrolled
NCT00034346 2007-12-24ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)AmgenPhase 2 Completed194 enrolled